Brad Arrhythmia Induced by Repeated Succinylcholine During Gynecological Laparoscopic Surgery
NCT ID: NCT02676011
Last Updated: 2016-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
120 participants
INTERVENTIONAL
2016-02-29
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy
NCT05997004
Effect of Magnesium Sulphate Pretreatment in Pediatric Abdominal Surgery
NCT05736744
Reversal of Neuromuscular Blockade and Perioperative Arrhythmias
NCT04720573
Haemodynamic Stability of Ketamine/Propofol Admixture "Ketofol" in Patient Undergoing Endoscopic Retrograde Cholangio Pancreatography
NCT02618668
Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
NCT05137288
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Intramuscular (IM) atropine (0.01 mg/kg) (1 ml) 30 minutes before induction of anesthesia, IV normal saline 10 ml 3 minutes before induction of anesthesia and normal saline mixed with second dose succinylcholine (1mg/kg) in 5 ml syringe with normal saline
IM atropine
Atropine (0.01 mg/kg) (1 ml) IM 30 minutes before induction of anesthesia
IV normal saline
IV 10 ml normal saline 3 minutes before induction of anesthesia
Normal saline mixed with second dose succinylcholine
Second dose succinylcholine (1 mg/kg) prepared to 5 ml syringe with normal saline
Group B
1 ml normal saline IM 30 minutes before induction of anesthesia, intravenously (IV) atropine (0.01 mg/kg) in 10 ml 3 minutes before induction of anesthesia and normal saline mixed with second dose succinylcholine (1mg/kg) in 5 ml syringe with normal saline
IV atropine
Atropine (0.01 mg/kg) intravenously (10 ml) 3 minutes before induction of anesthesia
IM normal saline
1 ml normal saline IM 30 minutes before induction of anesthesia
Normal saline mixed with second dose succinylcholine
Second dose succinylcholine (1 mg/kg) prepared to 5 ml syringe with normal saline
Group C
IM normal saline 1 ml normal 30 minutes before induction of anesthesia, IV normal saline 10 ml 3 minutes before induction of anesthesia and 1mg/kg atropine mixed with second dose succinylcholine (1mg/kg) in 5 ml syringe with normal saline
Atropine mixed with second dose succinylcholine
Atropine (0.01 mg/kg) added to the second dose succinylcholine (1mg/kg) prepared to 5 ml syringe with normal saline
IM normal saline
1 ml normal saline IM 30 minutes before induction of anesthesia
IV normal saline
IV 10 ml normal saline 3 minutes before induction of anesthesia
Group D
IM normal saline 1 ml normal 30 minutes before induction of anesthesia, IV normal saline 10 ml 3 minutes before induction of anesthesia and normal saline mixed with second dose succinylcholine (1mg/kg) in 5 ml syringe with normal saline
IM normal saline
1 ml normal saline IM 30 minutes before induction of anesthesia
IV normal saline
IV 10 ml normal saline 3 minutes before induction of anesthesia
Normal saline mixed with second dose succinylcholine
Second dose succinylcholine (1 mg/kg) prepared to 5 ml syringe with normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IM atropine
Atropine (0.01 mg/kg) (1 ml) IM 30 minutes before induction of anesthesia
IV atropine
Atropine (0.01 mg/kg) intravenously (10 ml) 3 minutes before induction of anesthesia
Atropine mixed with second dose succinylcholine
Atropine (0.01 mg/kg) added to the second dose succinylcholine (1mg/kg) prepared to 5 ml syringe with normal saline
IM normal saline
1 ml normal saline IM 30 minutes before induction of anesthesia
IV normal saline
IV 10 ml normal saline 3 minutes before induction of anesthesia
Normal saline mixed with second dose succinylcholine
Second dose succinylcholine (1 mg/kg) prepared to 5 ml syringe with normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diabetes Mellitus
* Thyroid disease
* Any endocrine disease
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sayed Kaoud Abd-Elshafy
Associate Professor (Anesthesiology and Critical Care)- College of Medicine-Assiut University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sayed abd elshafy, M
Role: PRINCIPAL_INVESTIGATOR
associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Asyut, Asyut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB000087133
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.